With the analysis among 131 patents, we discovered top 28 key players by total patent application. Adocia SA, Novo Nordisk A/S, Amylin Pharmaceuticals, Inc. are dominant in this area. They take 48.85% of the total patent filing.
Hovedstaden, Denmark
Patent: 19
California, United States
Patent: 17
Taiwan Province, China
Patent: 11
Indiana, United States
Patent: 6
New York, United States
Patent: 5
Valais, Switzerland
Patent: 5
Delaware, United States
Patent: 5
No data, please try another search term
With the analysis among related 41 patents applied in the last 5 years. We discover 7 most active companies in this area. The fast-growing Adocia SA, Eli Lilly & Co., MedImmune Ltd. take 85.37% of patent filing during this period.
Indiana, United States
Patent: 6
Cambridgeshire, United Kingdom
Patent: 3
Massachusetts, United States
Patent: 2
California, United States
Patent: 1
Anhui Sheng, China
Patent: 1
Zhejiang Sheng, China
Patent: 1
With the analysis among related 41 patents in last 5 years, we discover 5 new entrants. Eli Lilly & Co., MedImmune Ltd., Insulet Corp. are the most active new entrants in this area.
Indiana, United States
Patent: 6
Cambridgeshire, United Kingdom
Patent: 3
Massachusetts, United States
Patent: 2
Anhui Sheng, China
Patent: 1
Zhejiang Sheng, China
Patent: 1
With the analysis among 6 patents, we discovered top 5 universities and scientific research institutions by total patent application. Swiss Federal Institute of Technology Zurich, Jinan University, Shanghai Institute of Pharmaceutical Industry are dominant in this area. They take 83.33% of the total patent filing.
ZURICH, Switzerland
Patent: 3
Guangdong Sheng, China
Patent: 1
Shanghai Shi, China
Patent: 1
Guangdong Sheng, China
Patent: 1
Jiangsu Sheng, China
Patent: 1